SCHEMBL19494660

SCHEMBL19494660

NC(=O)c1cc(Sc2ccc(F)cc2)sc1NC(=O)c1ccc[nH]c1=O

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 1/20 0.46
▸ CFTR P13569 4/20 0.42
▸ IKBKB O14920 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ JAK2 O60674 1/20 0.41
▸ EIF2AK2 P19525 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ RAB9A P51151 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ KDM4E B2RXH2 3/20 0.37
▸ MAPT P10636 1/20 0.37
▸ GAA P10253 1/20 0.36
▸ PARP1 P09874 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16338476 0.79 CFTR (0.62) TYK2CFTRIKBKBMEN1JAK2
SCHEMBL19494512 0.78 IKBKB (0.41) CFTRIKBKBMEN1JAK2EIF2AK2
SCHEMBL19494662 0.78 TYK2 (0.44) TYK2CFTRIKBKBMEN1JAK2
SCHEMBL19494900 0.77 NPC1 (0.47) IKBKBMEN1JAK2KMT2ATDP1
SCHEMBL19494413 0.77 IKBKB (0.46) CFTRIKBKBMEN1JAK2EIF2AK2
SCHEMBL19494934 0.76 KMT2A (0.41) CFTRIKBKBMEN1JAK2EIF2AK2
SCHEMBL19494898 0.75 JAK2 (0.45) CFTRIKBKBMEN1JAK2EIF2AK2
SCHEMBL19494396 0.74 CFTR (0.43) CFTRIKBKBMEN1JAK2EIF2AK2
SCHEMBL19494442 0.73 MEN1 (0.42) CFTRIKBKBMEN1JAK2EIF2AK2
SCHEMBL19494938 0.72 MEN1 (0.41) CFTRIKBKBMEN1JAK2EIF2AK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback